The utility and interpretation of tuberculin skin tests in the Middle East

American Journal of Infection Control

Volumn 33, Issue 3, 2005, Pages 151-156

  Al Jahdali, Hamdan ^a,c   Memish, Ziad A ^a   Menzies, Dick ^b  

^a KING FAHAD NATIONAL GUARD HOSPITAL   (Saudi Arabia)

^b MCGILL UNIVERSITY   (Canada)

^c KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ALGERIA; BAHRAIN; BCG VACCINATION; DJIBOUTI; DRUG EFFECT; EGYPT; HEALTH PROGRAM; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; IRAN; IRAQ; JORDAN; KUWAIT; LABORATORY DIAGNOSIS; LEBANON; LIBYAN ARAB JAMAHIRIYA; MEDICAL PRACTICE; MIDDLE EAST; MOROCCO; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NEWBORN CARE; OMAN; QATAR; REVIEW; SAUDI ARABIA; SEROPREVALENCE; SOMALIA; SUDAN; SYRIAN ARAB REPUBLIC; TUBERCULIN TEST; TUBERCULOSIS; TUNISIA; UNITED ARAB EMIRATES; UTILIZATION REVIEW;

EID: 15744369268     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2005.01.005     Document Type: Article

References (56)

1. M.T. McKenna, E. McCray, and I. Onorato The epidemiology of tuberculosis among foreign-born persons in the United States, 1986 to 1993 N Engl J Med 332 1995 1071 1076
2. P.Q. Edwards, and L.B. Edwards Story of the tuberculin test from an epidemiologic viewpoint Am Rev Respir Dis 81 1960 1 47
3. L.B. Reichman Tuberculin skin testing. The state of the art Chest 76 1997 764 770
4. F.B. Seibrt, and J.T. Glen Tuberculin purified protein derivative: preparation and analysis of a large quantity for standard Am Rev Tuberc 44 1941 9 24
5. E. Lee, and R.S. Holzman Evolution and current use of the tuberculin test Clin Infect Dis 34 2002 365 370
6. American Thorasic Society Targeted tuberculin testing and treatment of latent tuberculosis infection Am J Respir Crit Care Med 161 2000 S221 S247
7. Centers for Disease Control and Prevention Targeted tuberculosis testing and treatment of latent tuberculosis infection MMWR 49 RR-6 2000 1 51
8. D. Burke Of postulates and peccadilloes: Robert Koch and vaccine (tuberculin) therapy for tuberculosis Vaccine 11 1993 795 804
9. C. Von Priquet Frequency of tuberculosis in childhood JAMA 52 1909 675 678
10. R.M. Jasmer, P. Nahid, and P.C. Hopewell Latent tuberculosis infection N Engl J Med 347 2002 1860 1866 23
11. C.E. Snider The tuberculin skin test Am Rev Respir Dis 125 1982 108 112
12. APIC position paper: Responsibility for interpretation of the PPD tuberculin skin test Am J Infect Control 27 1999 56 58
13. Jenkins C, Robalino DA. HIV/AIDS in the Middle East and North Africa. The costs of infection. The World Bank Report 2003. Available from: www.worldbank.org/MNA/mena.nsf. Accessed June 15, 2004.
14. D. Menzies What does tuberculin reactivity after bacillus Calmette-Guerin vaccination tell us? Clin Infect Dis 31 2000 S71 S74
15. Peter Martin. Guideline for tuberculosis control in New Zealand 2003: Mantoux testing 1-18. Available from: http://www.moh.govt.nz/moh.nsf. Accessed June 15, 2004.
16. D. Menzies, T.N. Tannenbaum, and J.M. FitzGerald Tuberculosis: 10. Prevention Can Med Assoc J 161 1999 717 724
17. J.M. Grange, J. Gibson, T.W. Osborn, C.H. Collins, and M.D. Yates What is BCG? Tubercle 64 1983 129 139
18. T.M. Doherty, and P. Anderson Tuberculosis vaccine development Curr Opin Pulm Med 8 2002 183 187
19. Centers for Disease Control and Prevention The role of BCG vaccine in the prevention and control of tuberculosis in the United States MMWR 45 RR-4 1996 1 14
20. M.A. Behr Correlation between BCG genomics and protective efficacy Scand J Infect Dis 33 2001 249 252
21. P.E.M. Fine, I.A.M. Carneiro, J.B. Milstien, and C.J. Clements Issues relating to the use of BCG in immunization programmes WHO/V&B/99.23 1999 1 42
22. World Health Organization. UNICEF review of national immunization coverage, 1980-2003. Available at: http://www.who.int/vaccines/globalsummary/ timeseries/tswucoveragebcg.htm. Accessed June 15, 2004.
23. World Health Organization BCG vaccination of the newborn: rationale and guidelines for country programmes 1986 World Health Organization Geneva, Switzerland
24. S.P. Tripathy Fifteen-year follow-up of the Indian BCG prevention trial International Union Against Tuberculosis. Proceedings of the 26th IUAT World Conference on Tuberculosis and Respiratory Diseases 1987 Professional postgraduate services international Singapore 69 72
25. Global strategies, policies and practices for immunization of adolescents. World Health Organization Geneva 1999. Available from: www.pendellmedical.com/pdf/ImmAdole.pdf#search-WHO/V&B/99.24. Accessed June 15, 2004.
26. S.R. Rosenthal, E. Loewinsohn, M.L. Graham, D. Liveright, M.G. Thorne, and V. Johnson BCG vaccination against tuberculosis in Chicago: a twenty-year study statistically analyzed Pediatrics 28 1961 622 641
27. J.D. Clemens, J.J.H. Chuong, and A.R. Feinstein The BCG controversy: a methodological and statistical reappraisal JAMA 249 1983 2362 2369
28. F.A. Al-Kassimi, M.S. Al-Hajjaj, I.O. Al-Orainey, and E.A. Bamgboye Does the protective effect of neonatal BCG correlates with vaccine-induced tuberculin reaction? Am J Respir Crit Care Med 152 1995 1575 1578
29. L.C. Rodrigues, V.K. Diwan, and J.G. Wheeler Protective effect of BCG against tuberculosis meningitis and miliary tuberculosis: a meta-analysis Int J Epidemiol 22 1993 1154 1158
30. G.A. Colditz, T.F. Brewer, C.S. Berkey, M.E. Wilson, E. Burdick, and H.V. Vineberg Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature JAMA 271 1994 698 702
31. O. Tidjani, A. Amedome, and H.G. Ten Dam The protective effect of BCG vaccination of the newborn against childhood tuberculosis in an African community Tubercle 67 1986 269 281
32. S. Padungchan, S. Konjanart, S. Kasirata, S. Daramas, and H.G. Ten Dam The effectiveness of BCG vaccination of the newborn against childhood tuberculosis in Bangkok Bull World Health Organ 64 1986 247 258
33. C. Shapiro, N. Cook, D. Evans, W. Willett, I. Fajardo, and D. Koch-Weser A case control study of BCG and childhood tuberculosis in Cali, Colombia Int J Epidemiol 14 1985 441 446
34. T.K. Young, and E. Hershfield A case-control study to evaluate the effectiveness of mass neonatal BCG vaccination among Canadian Indians Am J Public Health 76 1986 783 786
35. F.A. Al-Kassimi, A.K. Abdullah, M.S. Al-Hajjaj, I.O. Al-Orainey, E.A. Bamgboye, and M.N. Chowdhury Nationwide community survey of tuberculosis epidemiology in Saudi Arabia Tubercle Lung Dis 74 1993 254 260
36. V.W. Li, E.K. Joe, and K. Bowers BCG vaccination and interpretation of PPD test results Arch Dermatol 133 1997 916 917
37. L.O. Larsson, M. Magnusson, B.E. Skoogh, and A. Lind Sensitivity to sensitins and tuberculin in Swedish children: the influence of BCG vaccination Eur Respir J 5 1992 584 586
38. C.B.E. Chee, C.H. Soh, I.C. Boudville, S.S. Chor, and Y.T. Wang Interpretation of the tuberculin skin test in Mycobacterium bovis BCG-vaccinated Singaporean schoolchildren Am J Respir Crit Care Med 164 2001 958 961
39. O. Horwitz, and K. Bunch-Christensen Correlation between tuberculin sensitivity after 2 months and 5 years among BCG vaccinated subjects Bull World Health Organ 47 1972 49 58
40. S. Karalliedde, L.P. Katugaha, and C.G. Uragoda Tuberculin response of Sri Lankan children after BCG vaccination at birth Tubercle 68 1987 33 38
41. E.W. Abrahams Tuberculin hypersensitivity following BCG vaccination in Brisbane school children Tubercle 60 1979 109 113
42. G.W. Comstock, L.B. Edwards, and H. Nabangxang Tuberculin sensitivity eight to fifteen years after BCG vaccination Am Rev Respir Dis 103 1971 572 575
43. C.J. Stewart Skin Sensitivity to human, avian and BCG PPDs after BCG vaccination Tubercle 49 1968 84 91
44. D. Menzies, and B. Vissandjee Effect of bacilli Calmette-Guerin vaccination on tuberculin reactivity Am Rev Respir Dis 145 1992 621 625
45. Centers for Disease Control and Prevention Tuberculin skin test survey in a pediatric population with high BCG vaccination coverage-Botswana, 1996 MMWR 46 RR-36 1997 846 851
46. L. Wang, M.O. Turner, R.K. Elwood, M. Schulzer, and J.M. Fitzgerald A meta-analysis of the effect of BCG vaccination on tuberculin skin test measurements Thorax 57 2002 804 809
47. R. Zamman Tuberculosis in Saud Arabia: epidemiology and incidence of Mycobacterium tuberculosis and other mycobacterial species Tubercle 72 1991 43 49
48. A.R. Bahrmand, H. Madani, G. Samar, L. Khalilzadeah, V.V. Bakayev, and M. Yaghli Detection and identification of non-tuberculous mycobacterial infections in 6,472 tuberculosis suspected patients Scand J Infect Dis 28 1996 275 278
49. Global tuberculosis control - surveillance, planning, financing. WHO Report 2004. WHO.HTM/TB/2004.331. Geneva, Switzerland. Available from: http://www.who.int/tb/publications/global_report. Accessed June 15, 2004.
50. K. Styblo Recent advances in epidemiological research in tuberculosis Adv Tuberc Res 20 1980 1 63
51. M. Azbite Tuberculin survey in Ethiopia Kekkaku 67 1992 539 544
52. F. Kebede Tuberculin conversion in children after BCG vaccination Ethiop Med J 31 1993 265 270
53. M.I. Khan Survey of tuberculosis infection in schoolchildren in Bahrain Tubercle 63 1982 287 289
54. D. Menzies Interpretation of repeated tuberculin test. Boosting, conversion and reversion Am J Respir Crit Care Med 159 1999 15 21
55. N.M. Richards, K.E. Nelson, M.D. Batt, D. Hackbarth, and J.G. Heidenreich Tuberculin test conversion during repeated skin testing, associated with sensitivity to nontuberculous mycobacteria Am Rev Respir Dis 120 1979 59 65
56. A.M. Almazrou Booster effect of two-step tuberculin skin testing among hospital employees from areas with a high prevalence of tuberculosis Infect Control Hosp Epidemiol 25 2004 1117 1120